Use of intramuscular prostaglandin for failure of mid-trimester abortion by another method
- 30 November 1980
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 22 (6) , 623-642
- https://doi.org/10.1016/0010-7824(80)90088-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Complications from Legally-Induced AbortionObstetrical & Gynecological Survey, 1979
- Use of intramuscular 15(S)-15-methyl prostaglandin F2α in failed abortionsAmerican Journal of Obstetrics and Gynecology, 1979
- The Effects of Intramuscular Injections of 15(S)-15-Methyl Prostaglandin F2α in Failed Abortions**Supported by Grant 73049 from The Rockefeller Foundation and by The Upjohn Company, Kalamazoo, Mich.††Presented at the Ninth World Congress on Fertility and Sterility and the Thirty-Third Annual Meeting of The American Fertility Society, April 12 to 16, 1977, Miami Beach, Fla.Fertility and Sterility, 1977
- Therapeutic abortion of early human gestation with intramuscular 15-methyl prostaglandin F2αContraception, 1976
- Midtrimester abortion with intramuscular injection of 15-methyl-prostaglandin F2αContraception, 1975
- Oxytocin administration, instillation-to-abortion time, and morbidity associated with saline instillationAmerican Journal of Obstetrics and Gynecology, 1975
- Serial intramuscular injections of 15(S)-15-methyl-prostaglandin F2α in the induction of abortionProstaglandins, 1975
- Dilatation and evacuation at 13 to 15 weeks' gestation versus intra-amniotic saline after 15 weeks' gestationContraception, 1974
- Oxytocin administration in mid-trimester saline abortionsAmerican Journal of Obstetrics and Gynecology, 1973
- NOVEL PROSTAGLANDIN SYNTHESESAnnals of the New York Academy of Sciences, 1971